A CD4-derived peptide carrier blocks acute HIV-1 infection in vitro and binds to gp120 in the presence of Walter-Reed stage 1-6 HIV+ sera

V. Ghetie, T. Wheeler, D. Scott, J. W. Uhr, E. S. Vitetta

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A peptide containing amino acid residues 41-84 of the CD4 molecule was synthetized and coupled through a thioether bond to human serum albumin. This conjugate bound to gp120 with an affinity that was half that of CD4 and blocked the HIV infection in vitro with an efficacy tenfold lower than that of CD4. More importantly, the CD4 peptide-human serum albumin conjugate could bind to gp120 in the presence of HIV+ sera from 18 Walter Reed stage 1-6 patients.

Original languageEnglish (US)
Pages (from-to)1945-1948
Number of pages4
JournalAIDS Research and Human Retroviruses
Volume8
Issue number11
StatePublished - 1992

Fingerprint

Serum Albumin
HIV Infections
HIV-1
CD4 Antigens
Peptides
Sulfides
Serum
HIV
Amino Acids
In Vitro Techniques

ASJC Scopus subject areas

  • Immunology
  • Virology

Cite this

A CD4-derived peptide carrier blocks acute HIV-1 infection in vitro and binds to gp120 in the presence of Walter-Reed stage 1-6 HIV+ sera. / Ghetie, V.; Wheeler, T.; Scott, D.; Uhr, J. W.; Vitetta, E. S.

In: AIDS Research and Human Retroviruses, Vol. 8, No. 11, 1992, p. 1945-1948.

Research output: Contribution to journalArticle

@article{a858152394824c71a8b70125ad68a86a,
title = "A CD4-derived peptide carrier blocks acute HIV-1 infection in vitro and binds to gp120 in the presence of Walter-Reed stage 1-6 HIV+ sera",
abstract = "A peptide containing amino acid residues 41-84 of the CD4 molecule was synthetized and coupled through a thioether bond to human serum albumin. This conjugate bound to gp120 with an affinity that was half that of CD4 and blocked the HIV infection in vitro with an efficacy tenfold lower than that of CD4. More importantly, the CD4 peptide-human serum albumin conjugate could bind to gp120 in the presence of HIV+ sera from 18 Walter Reed stage 1-6 patients.",
author = "V. Ghetie and T. Wheeler and D. Scott and Uhr, {J. W.} and Vitetta, {E. S.}",
year = "1992",
language = "English (US)",
volume = "8",
pages = "1945--1948",
journal = "AIDS Research and Human Retroviruses",
issn = "0889-2229",
publisher = "Mary Ann Liebert Inc.",
number = "11",

}

TY - JOUR

T1 - A CD4-derived peptide carrier blocks acute HIV-1 infection in vitro and binds to gp120 in the presence of Walter-Reed stage 1-6 HIV+ sera

AU - Ghetie, V.

AU - Wheeler, T.

AU - Scott, D.

AU - Uhr, J. W.

AU - Vitetta, E. S.

PY - 1992

Y1 - 1992

N2 - A peptide containing amino acid residues 41-84 of the CD4 molecule was synthetized and coupled through a thioether bond to human serum albumin. This conjugate bound to gp120 with an affinity that was half that of CD4 and blocked the HIV infection in vitro with an efficacy tenfold lower than that of CD4. More importantly, the CD4 peptide-human serum albumin conjugate could bind to gp120 in the presence of HIV+ sera from 18 Walter Reed stage 1-6 patients.

AB - A peptide containing amino acid residues 41-84 of the CD4 molecule was synthetized and coupled through a thioether bond to human serum albumin. This conjugate bound to gp120 with an affinity that was half that of CD4 and blocked the HIV infection in vitro with an efficacy tenfold lower than that of CD4. More importantly, the CD4 peptide-human serum albumin conjugate could bind to gp120 in the presence of HIV+ sera from 18 Walter Reed stage 1-6 patients.

UR - http://www.scopus.com/inward/record.url?scp=0027043191&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027043191&partnerID=8YFLogxK

M3 - Article

C2 - 1489581

AN - SCOPUS:0027043191

VL - 8

SP - 1945

EP - 1948

JO - AIDS Research and Human Retroviruses

JF - AIDS Research and Human Retroviruses

SN - 0889-2229

IS - 11

ER -